4,6-Dichloro-1-Phenyl-1H-Pyrazolo[3,4-D]Pyrimidine

The primary applications of 4,6-dichloro-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine lie in medicinal chemistry as potential anticancer agents. Its ability to inhibit CDK2 makes it valuable in developing targeted therapies for various cancers. Additionally, its structural characteristics allow for modifications that could enhance its pharmacological profile or selectivity against specific cancer types.

Research indicates that 4,6-dichloro-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine exhibits significant biological activity, particularly as an inhibitor of cyclin-dependent kinase 2 (CDK2), which is crucial in cell cycle regulation. In vitro studies have shown that compounds within this class can inhibit tumor cell proliferation effectively, making them promising candidates for cancer therapeutics. The compound has demonstrated cytotoxic effects against various cancer cell lines, including MCF-7 (breast cancer) and HCT-116 (colon cancer), with IC50 values in the nanomolar range.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.